DE602006013109D1 - Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs - Google Patents

Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs

Info

Publication number
DE602006013109D1
DE602006013109D1 DE602006013109T DE602006013109T DE602006013109D1 DE 602006013109 D1 DE602006013109 D1 DE 602006013109D1 DE 602006013109 T DE602006013109 T DE 602006013109T DE 602006013109 T DE602006013109 T DE 602006013109T DE 602006013109 D1 DE602006013109 D1 DE 602006013109D1
Authority
DE
Germany
Prior art keywords
diagnosis
pancreatic cancer
marker protein
marker
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006013109T
Other languages
English (en)
Inventor
Setsuo Hirohashi
Kazufumi Honda
Tesshi Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Health Sciences Foundation
Original Assignee
Japan Health Sciences Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Health Sciences Foundation filed Critical Japan Health Sciences Foundation
Publication of DE602006013109D1 publication Critical patent/DE602006013109D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
DE602006013109T 2005-03-14 2006-01-26 Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs Active DE602006013109D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005070512 2005-03-14
PCT/JP2006/301243 WO2006098087A1 (ja) 2005-03-14 2006-01-26 膵臓癌診断用マーカータンパク質

Publications (1)

Publication Number Publication Date
DE602006013109D1 true DE602006013109D1 (de) 2010-05-06

Family

ID=36991443

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006013109T Active DE602006013109D1 (de) 2005-03-14 2006-01-26 Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs

Country Status (5)

Country Link
US (1) US20090004671A1 (de)
EP (1) EP1870711B1 (de)
JP (1) JP5200246B2 (de)
DE (1) DE602006013109D1 (de)
WO (1) WO2006098087A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5140809B2 (ja) * 2007-07-25 2013-02-13 財団法人ヒューマンサイエンス振興財団 修飾α−フィブリノゲンタンパク質またはその免疫原性断片
JP5422785B2 (ja) * 2008-09-12 2014-02-19 国立大学法人名古屋大学 質量分析法を利用した複数癌腫の血液検出のための方法および生物マーカー
JP2010175452A (ja) * 2009-01-30 2010-08-12 Japan Health Science Foundation 膵臓癌の検出法
SG10201405974SA (en) * 2009-10-01 2014-10-30 Phenomenome Discoveries Inc Serum-based biomarkers of pancreatic cancer and uses thereof for diseasedetection and diagnosis
EP3355057A3 (de) * 2010-06-01 2018-12-12 Metanomics Health GmbH Mittel und verfahren zur diagnose von bauchspeicheldrüsenkrebs bei einer person
CA3189270A1 (en) 2013-10-01 2015-04-09 Toray Industries, Inc. Method for detecting pancreatic tumor, antibodies, and kit for the detection of pancreatic tumor
EP3267197B1 (de) 2015-03-02 2020-09-16 Toray Industries, Inc. Pankreasfehlfunktionsnachweisverfahren und nachweiskit
DK179161B1 (en) * 2016-05-26 2017-12-18 Man Diesel & Turbo Filial Af Man Diesel & Turbo Se Tyskland A large two-stroke compression-ignited internal combustion engine with fuel injection system for low flashpoint fuel and a fuel valve therefore
WO2018134952A1 (ja) * 2017-01-19 2018-07-26 株式会社島津製作所 分析データ解析方法および分析データ解析装置
JPWO2022202826A1 (de) 2021-03-24 2022-09-29

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer
WO2001071360A2 (en) * 2000-03-20 2001-09-27 Eastern Virginia Medical School Prostate cancer markers
JP4424988B2 (ja) * 2001-09-25 2010-03-03 国立がんセンター総長 新規なスクリーニング法によるがんマーカーの探索

Also Published As

Publication number Publication date
WO2006098087A1 (ja) 2006-09-21
EP1870711B1 (de) 2010-03-24
EP1870711A1 (de) 2007-12-26
JP5200246B2 (ja) 2013-06-05
EP1870711A4 (de) 2008-07-16
JPWO2006098087A1 (ja) 2008-08-21
US20090004671A1 (en) 2009-01-01

Similar Documents

Publication Publication Date Title
DE602006013109D1 (de) Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs
FIC20230027I1 (fi) Tremelimumabi
DE602005020209D1 (de) System zur Evaluierung von Herzstörungen
DE602005025340D1 (de) Chimäre adenoviren zur verwendung in der krebsbehandlung
FI20050192A0 (fi) Järjestely tiedon esittämiseksi ja päivittämiseksi
DE602006015297D1 (de) 3-azetidincarbonsäure-derivate zur verwendung als immunsuppressiva
DE602006009287D1 (de) Verfahren zur anregung der darmflora
DE602006019133D1 (de) Verfahren zur nicht-invasiven glucosemessung
AT502349A3 (de) Verfahren zur auswertung von touch-signalen und touch-einheit
DE602006016480D1 (de) Behandlungsinstrument für ein endoskop
DE602006012262D1 (de) Behandlunsgsinstrument für ein Endoskop
FI20055198A (fi) Visualisointitekniikka biologista informaatiota varten
ATE451967T1 (de) Auskleidungskomponente zur verwendung in der bergbau- oder abbauindustrie
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
DE602006009513D1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
EE200600030A (et) Proteiinkinaasi fluorestsents-sond
DE602004025215D1 (de) Tastsonde
ATE507222T1 (de) 1,1-dioxo-thiomorpholinyl-indolyl-methanon- derivate zur verwendung als h3-modulatoren
DE602006021735D1 (de) Behandlungsinstrument für ein endoskop
DE502005000300D1 (de) Tastkopf
ATE490957T1 (de) Tetrahydrochinoline zur verwendung als modulatoren des mitotischen motor- protein eg5
DE112006000481A5 (de) Verfahren zur Bestimmung der elastischen Verformung von Bauteilen
DE602006013581D1 (de) Funktionstestverfahren
DE112004002986A5 (de) Prüfanlage zur zerstörungsfreien Materialprüfung
ATE462139T1 (de) Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: SAMSON & PARTNER, PATENTANWAELTE, 80538 MUENCHEN

8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1870711

Country of ref document: EP

Representative=s name: GRUENECKER, KINKELDEY, STOCKMAIR & SCHWANHAEUS, DE